questionText: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the UK-US Pharmaceuticals Deal concluded in December 2025 on (a) NHS procurement costs and (b) consumer access to affordable medicines before any provisions of that Deal take effect.
answerText: There are no current plans to publish an impact assessment or modelling on the United Kingdom and United States’ pharmaceutical trade deal. Further detail on the deal will be shared in due course.Tens of thousands of National Health Service patients will ...
heading: Trade Agreements: USA